Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials

The potential benefit of long-term dual antiplatelet therapy (DAPT) for secondary prevention of atherothrombotic events is unclear. Data from different randomized controlled trials (RCT) using different agents in different subgroups showed inconsistent results.

Source: Cardiovascular Revascularization Medicine - July 19, 2016 Category: Cardiology Authors: Zaher Fanari, Amratash Malodiya, Sandra A. Weiss, Sumaya Hammami, Paul Kolm, William S. Weintraub Source Type: research